- Home
- SMTI vs ADCT Comparison
SMTI vs ADCT Comparison
Compare SMTI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- ADCT
- Stock Information
- Founded
- SMTI 1982
- ADCT 2011
- Country
- SMTI United States
- ADCT Switzerland
- Employees
- SMTI N/A
- ADCT N/A
- Industry
- SMTI Medical/Dental Instruments
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- ADCT Health Care
- Exchange
- SMTI Nasdaq
- ADCT Nasdaq
- Market Cap
- SMTI 288.2M
- ADCT 224.3M
- IPO Year
- SMTI N/A
- ADCT 2020
- Fundamental
- Price
- SMTI $36.64
- ADCT $2.97
- Analyst Decision
- SMTI Buy
- ADCT Strong Buy
- Analyst Count
- SMTI 1
- ADCT 5
- Target Price
- SMTI $44.00
- ADCT $7.33
- AVG Volume (30 Days)
- SMTI 35.0K
- ADCT 897.3K
- Earning Date
- SMTI 11-12-2024
- ADCT 11-07-2024
- Dividend Yield
- SMTI N/A
- ADCT N/A
- EPS Growth
- SMTI N/A
- ADCT N/A
- EPS
- SMTI N/A
- ADCT N/A
- Revenue
- SMTI $78,056,873.00
- ADCT $70,717,000.00
- Revenue This Year
- SMTI $29.95
- ADCT $6.38
- Revenue Next Year
- SMTI $19.68
- ADCT $11.73
- P/E Ratio
- SMTI N/A
- ADCT N/A
- Revenue Growth
- SMTI 24.66
- ADCT N/A
- 52 Week Low
- SMTI $26.00
- ADCT $0.94
- 52 Week High
- SMTI $43.25
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- SMTI 56.60
- ADCT 41.63
- Support Level
- SMTI $34.50
- ADCT $1.80
- Resistance Level
- SMTI $37.60
- ADCT $2.38
- Average True Range (ATR)
- SMTI 1.88
- ADCT 0.20
- MACD
- SMTI -0.23
- ADCT 0.00
- Stochastic Oscillator
- SMTI 59.81
- ADCT 52.27
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.